Supply Chain Management

Rubrik: Fachthemen

(Treffer aus pharmind, Nr. 10, Seite 1452 (2015))

Packowski J | Gmür A | Reuter C

Supply Chain Management / Part 1: From cost to value · Packowski J, Gmür A, Reuter C · Camelot Management Consultants AG, ¹Mannheim und ²Basel, Switzerland
Pharmaceutical companies presently face a multitude of market developments. Most of these developments have the same root cause: a shift in product development from the time-worn focus on physical products to a comprehensive consideration of actual patient needs. While this sounds very simple, it has to be understood in the context of an industry where the patients as the end customers traditionally have been neither in direct contact with producers nor able to make buying decisions regarding complex drugs on their own. However, innovative (sometimes even individualized) drugs and new information technologies require and enable new information flows and affect ...

Hidden Treasures in Pharma Logistics

Rubrik: Fachthemen

(Treffer aus pharmind, Nr. 01, Seite 52 (2015))

Gmür A | Reuter C

Hidden Treasures in Pharma Logistics / Converting logistics contracts from percentage-of-sales to activity-based costing · Gmür A, Reuter C · Camelot Management Consultants AG, Basel, Schweiz
The transition of pharma logistics contracts from a percentage-of-sales model to an activity-based costing model not only has a significant cost reduction potential, but it is also an enabler to keep up with current pharmaceutical trends and the rising complexity in today's global pharmaceutical supply chains. A management consulting firm accompanied one of its customers along this route and now presents a proven approach on how to succeed in this transition. This article comprises an exemplary calculation of the differences between the discussed pricing models, the future developments in secondary distribution and finally, a case study providing a short overview ...